Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study

ConclusionAs BTFC offered better tolerability than DTFC with comparable reduction in IOP, we recommend it as an alternative for patients who experience ocular discomfort with DTFC-prostaglandin analogue combination therapy.Trial Registration NumberjRCTs051190125.

http://link.springer.com/10.1007/s12325-023-02589-9

Source: Advances in Therapy - July 15, 2023 Category: Drugs & Pharmacology Source Type: research